Floatz logo

Advm-043

Alpha 1-Antitrypsin Deficiency

Adverum Biotechnologies, Inc.gene_therapyPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

25 Active assets in the Alpha 1-Antitrypsin Deficiency cohort.

Asset / SponsorPhaseRating
Alpha-1-Proteinase Inhibitor
Grifols Therapeutics LLC
Phase 4A
.ALPHA.-1 PROTEASE INHIBITOR
Grifols Therapeutics LLC
Phase 4A
NORMAL HUMAN SERUM ALBUMIN
Baxalta now part of Shire
Phase 4BBB
.ALPHA.-1 PROTEASE INHIBITOR
Grifols Therapeutics LLC
Phase 3BB
Alpha-1-Proteinase Inhibitor
Grifols Therapeutics LLC
Phase 3BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →